In September 2016 the UMCG Groningen started an EU funded project PRONKJEWAIL. The research aims to protect people who are particularly susceptible to infectious diseases. PRONKJEWAIL (‘a real gem’) will train 16 PhD students in the field of hospital care and infection. PRONKJEWAIL is recruiting 16 international PhD students, who will be trained in research, transferable skills, as well as network and capacity building. They will be guided by experienced supervisors from the departments of Medical Microbiology, Internal Medicine, Intensive Care, Clinical Pharmacy and Pharmacology, Paediatrics, Surgery, Cell Biology, and Pharmacoepidemiology and Pharmacoeconomics at the UMCG. 26 international partner organisations, including 14 private sector partners, are committed to support ESR training via mentoring, courses and secondments.
Research projects are clustered in four thematic Pillars:
- vaccines and primary prevention;
- personalized detection and infection prevention;
- iatrogenic influence on the microbiome and
- personalized therapy/stewardship.
Each Pillar integrates fundamental, translational and clinical/epidemiological research projects.
PRONKJEWAIL will strengthen the regional and European research into infections and, ultimately, it will contribute to enhanced public health and stimulate innovation in this field. By providing excellent training, PRONKJEWAIL will develop new talent within the next generation of medical researchers thereby strengthening the European Research Area. Locally PRONKJEWAIL will impact innovative SMEs in the field of hospital care, translational research and medtech.
PRONKJEWAIL has received funding from the European Union’s Horizon2020 research and innovation programme under the Marie Sclodowska-Curie grant agreement 713660.